Advanced systems engineered for precision and reliability
Shenzhen BioX Medical Co., Ltd. is a globally recognized professional manufacturer specializing in molecular diagnostic analysis systems and clinical laboratory innovations. Established in 2017 in Shenzhen—the "Silicon Valley" of MedTech—we lead the industry in genetic testing and automation.
Operating a state-of-the-art facility exceeding 9,000 square meters, we employ over 200 dedicated professionals. Our capacity ensures that high-demand orders for nucleic acid testing platforms and biomarker equipment are met with surgical precision.
Serving markets across Europe, North America, and Asia-Pacific, BioX Medical offers flexible OEM and ODM services. We empower diagnostic companies to bring proprietary technologies to life through our proven industrial ecosystem.
Square Meters Facility
R&D Experts
Founded Year
Countries Served
The global healthcare landscape is undergoing a seismic shift towards Precision Medicine. In this context, laboratory testing innovations are no longer just tools—they are the bedrock of clinical decision-making. At BioX Medical, we address the macro-level challenges of modern diagnostics: increasing throughput, reducing human error, and ensuring total data traceability.
Our comprehensive solutions integrate advanced automation with intelligent data management. From the SCITEK Real-Time Fluorescence PCR System to integrated gel imaging, every piece of equipment is designed to optimize laboratory workflows. By reducing the time-to-result, we empower hospitals and research institutions to respond faster to emerging health threats.
The integration of AI-driven analysis and cloud-based diagnostics is the next frontier. BioX Medical is at the forefront, developing systems that not only extract and detect nucleic acids but also provide preliminary analytical insights through integrated software, reducing the cognitive load on laboratory technicians.
Furthermore, the demand for Point-of-Care Testing (POCT) is skyrocketing. Our portable solutions, such as the Tianlong Suitcase PCR System, demonstrate our commitment to decentralized diagnostics, ensuring that high-quality molecular testing is accessible even in resource-limited or remote environments.
Eliminating manual pipetting and extraction errors through platforms like the Biobase BK-HS32. Focusing on "Sample-in, Result-out" architectures to maximize reliability.
Expanding detection capabilities to identify multiple pathogens (e.g., HPV, Respiratory Panels) in a single run, increasing the diagnostic value of every patient sample.
Leveraging IoT and 5G connectivity for real-time equipment monitoring, predictive maintenance, and seamless LIS (Laboratory Information System) integration.
Enterprise-level procurement for laboratory equipment involves more than just selecting a product; it requires a strategic partnership. BioX Medical understands the complexities of international supply chains.
Extended portfolio covering chemical analysis and medical imaging
The role of a Laboratory Testing Innovations Manufacturer extends beyond the production line. It is about understanding the delicate balance between clinical necessity and engineering possibility. Shenzhen BioX Medical Co., Ltd. remains committed to advancing the global evolution of molecular diagnostics. By providing reliable, scalable, and innovative diagnostic systems, we support clinical research and precision healthcare initiatives on a global scale.
Our multidisciplinary approach—combining mechanical engineering, molecular biology, and software development—ensures that our partners receive solutions that are not only technologically superior but also commercially viable. Whether you are a distributor in Latin America or a research hospital in Europe, BioX Medical is your trusted factory for the next generation of laboratory excellence.
BioX Medical
